Tafamidis: A Game Changer in Transthyretin Cardiomyopathy? A Systematic Review of Efficacy and Safety

被引：0
|
作者：
Hussain, Bilal
Hamza, Mohammad
Sattar, Yasar
Patel, Bansari
Song, David
Patel, Neel N.
Duhan, Sanchit
Cheema, Mustafa Sajjad
Naeem, Minahil
Waqar, Hafiza Hareem
Lactana, Sharaad
Alraies, M. Chadi C.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Amyloidosis; Mortality; Heart Failure; Echocardiography;
D O I：
10.1161/circ.148.suppl_1.16556
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16556
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TAFAMIDIS - A GAME-CHANGER IN TRANSTHYRETIN CARDIOMYOPATHY: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY
    Song, David
    Antony, Ronny
    Jain, Samkit
    Singh, Ranbir
    Shah, Vaibhav
    Rastogi, Tanya
    Batth, Simrat
    Mozell, Daniel
    Kim, Andrew
    Bogart, Michael
    Lieber, Joseph
    CHEST, 2023, 164 (04) : 307A - 307A
  • [2] Efficacy of tafamidis in transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis
    Sukaina, Mahnoor
    Rehman, Shafi
    Waheed, Marium
    Shehryar, Muhammad
    Rasool, Raffat
    Ahmed, Nimra
    Ochani, Sidhant
    Hasibuzzaman, Md. Al
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (01): : 433 - 438
  • [3] A Systematic Review of Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Singh, Bishnu Mohan
    Bohara, Narayan
    Gautam, Kamal
    Basnet, Madan
    Sistu, K. C.
    Binod, K. C.
    Raut, Anuradha
    Phudong, Abisha
    Gautam, Jeevan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [4] Efficacy and Safety of Tafamidis Doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)
    Hanna, Mazen
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Judge, Daniel P.
    Merlini, Giampaolo
    Maurer, Mathew S.
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Witteles, Ronald
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S77 - S78
  • [5] Tafamidis: A Review in Transthyretin Amyloid Cardiomyopathy
    Lamb, Yvette N.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (01) : 113 - 121
  • [6] Tafamidis: A Review in Transthyretin Amyloid Cardiomyopathy
    Yvette N. Lamb
    American Journal of Cardiovascular Drugs, 2021, 21 : 113 - 121
  • [7] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis
    Wang, Jie
    Chen, Hongyu
    Tang, Zihuan
    Zhang, Jinquan
    Xu, Yuanwei
    Wan, Ke
    Hussain, Kifah
    Gkoutos, Georgios, V
    Han, Yuchi
    Chen, Yucheng
    ECLINICALMEDICINE, 2023, 63
  • [8] Tafamidis for Transthyretin Amyloid Cardiomyopathy
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 773 - 773
  • [9] Tafamidis for Transthyretin Amyloid Cardiomyopathy
    Manion, Christopher
    Sharma, Umesh C.
    Rapezzi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (02): : 196 - 196
  • [10] Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Hanna, Mazen
    Judge, Daniel P.
    Merlini, Giampaolo
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Riley, Steven
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Witteles, Ronald
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 277 - 285
12345